Non-coding genome functions in diabetes

Journal of Molecular Endocrinology

Volumn 56, Issue 1, 2015, Pages R1-R20

  Cebola, Inês ^a   Pasquali, Lorenzo ^b,c,d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c JOSEP CARRERAS LEUKAEMIA RESEARCH INSTITUTE IJC   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Diabetes (all); Diabetes II; Gene regulation; Islet cells; Pancreatic cell

Indexed keywords

UNTRANSLATED RNA; SPACER DNA;

ENHANCER REGION; GENE CONTROL; GENETIC CODE; GENETIC VARIABILITY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PANCREAS ISLET CELL; PANCREATIC TISSUE; PRIORITY JOURNAL; REVIEW; ANIMAL; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN GENOME; REGULATORY SEQUENCE;

ANIMALS; DIABETES MELLITUS, TYPE 2; DNA, INTERGENIC; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 84950104000     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-15-0197     Document Type: Review

References (165)

1. Aguilo F, Zhou M-M & Walsh MJ 2011 Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Research 71 5365–5369. (doi:10.1158/0008-5472.CAN-10-4379)
2. Arnes L & Sussel L 2015 Epigenetic modifications and long noncoding RNAs influence pancreas development and function. Trends in Genetics 31 290–299. (doi:10.1016/j.tig.2015.02.008)
3. Avrahami D, Li C, Zhang J, Schug J, Avrahami R, Rao S, Stadler MB, Burger L, Schübeler D, Glaser B & Kaestner KH 2015 Aging-dependent demethylation of regulatory elements correlates with chromatin state and improved β cell function. Cell Metabolism 22 619–632. (doi:10.1016/j.cmet.2015.07.025)
4. Beck-Nielsen H, Vaag A, Poulsen P & Gaster M 2003 Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects–experiences from relatives and twin studies. Best Practice & Research. Clinical Endocrinology & Metabolism 17 445–467. (doi:10.1016/S1521-690X(03)00041-1)
5. Bell AC & Felsenfeld G 2000 Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405 482–485. (doi:10.1038/35013100)
6. Bell GI & Polonsky KS 2001 Diabetes mellitus and genetically programmed defects in b-cell function. Nature 414 788–791. (doi:10.1038/414788a)
7. Bell CG, Finer S, Lindgren CM, Wilson GA, Rakyan VK, Teschendorff AE, Akan P, Stupka E, Down TA et al. 2010 Prokopenko I. Integrated genetic and epigenetic analysis identifies haplotype-specificmethylation in the FTO type 2 diabetes and obesity susceptibility locus. PLoS ONE 5 e14040. (doi:10.1371/journal.pone.0014040)
8. Bhandare R, Schug J, Le Lay J, Fox A, Smirnova O, Liu C, Naji A & Kaestner KH 2010 Genome-wide analysis of histone modifications in human pancreatic islets. Genome Research 20 428–433. (doi:10.1101/gr.102038.109)
9. Bonnefond A, Bonnefond A, Clément N, Clément N, Fawcett K, Fawcett K, Yengo L, Vaillant E, Vaillant E, Guillaume J-L et al. 2012 Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nature Genetics 44 297–301. (doi:10.1038/ng.1053)
10. Borowiec M, Liew CW, Thompson R, Boonyasrisawat W, Hu J, Mlynarski WM, Khattabi El I, Kim S-H, Marselli L, Rich SS et al. 2009 Mutations at the BLK locus linked to maturity onset diabetes of the young and β-cell dysfunction. PNAS 106 14460–14465. (doi:10.1073/pnas.0906474106)
11. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, Karczewski KJ, Park J, Hitz BC, Weng S et al. 2012 Annotation of functional variation in personal genomes using RegulomeDB. Genome Research 22 1790–1797. (doi:10.1101/gr.137323.112)
12. van de Bunt M, Gaulton KJ, Parts L, Morán I, Johnson PR, Lindgren CM, Ferrer J, Gloyn AL & McCarthy MI 2013 The miRNA profile of human pancreatic islets and β-cells and relationship to type 2 diabetes pathogenesis. PLoS ONE 8 e55272. (doi:10.1371/journal.pone. 0055272)
13. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A & Rinn JL 2011 Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes and Development 25 1915–1927. (doi:10.1101/gad.17446611)
14. Carrasco M, Delgado I, Soria B, Martín F & Rojas A 2012 GATA4 and GATA6 control mouse pancreas organogenesis. Journal of Clinical Invesigation 122 3504–3515. (doi:10.1172/JCI63240)
15. Cebola I, Rodríguez-Seguí SA, Cho CH-H, Bessa J, Rovira M, Luengo M, Chhatriwala M, Berry A, Ponsa-Cobas J, Maestro MA et al. 2015 TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors. Nature Cell Biology 17 615–626. (doi:10.1038/ncb3160)
16. Chambers JC, Chambers JC, Loh M, Loh M, Lehne B, Lehne B, Drong A, Drong A, Kriebel J, Motta V et al. 2015 Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes & Endocrinology 3 526–534. (doi:10.1016/S2213-8587(15)00127-8)
17. Cho CHH, Hannan NRF, Docherty FM, Docherty HM, Joåo Lima M, Trotter MWB, Docherty K & Vallier L 2012 Inhibition of activin/nodal signalling is necessary for pancreatic differentiation of human pluripotent stem cells. Diabetologia 55 3284–3295. (doi:10.1007/s00125-012-2687-x)
18. Claussnitzer M, Dankel SN, Klocke B, Grallert H, Glunk V, Berulava T, Lee H, Oskolkov N, Fadista J, Ehlers K et al. 2014 Leveraging cross-species transcription factor binding site patterns: from diabetes risk loci to disease mechanisms. Cell 156 343–358. (doi:10.1016/j.cell.2013.10.058)
19. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA et al. 2013 Multiplex genome engineering using CRISPR/Cas systems. Science 339 819–823. (doi:10.1126/science.1231143)
20. Corradin O, Saiakhova A, Akhtar-Zaidi B, Myeroff L, Willis J, Lari RC-S, Lupien M, Markowitz S & Scacheri PC 2014 Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Genome Research 24 1–13. (doi:10.1101/gr.164079.113)
21. Coventry A, Bull-Otterson LM, Liu X, Clark AG, Maxwell TJ, Crosby J, Hixson JE, Rea TJ, Muzny DM, Lewis LR et al. 2010 Deep resequencing reveals excess rare recent variants consistent with explosive population growth. Nature Communications 1 131. (doi:10.1038/ncomms1130)
22. Dayeh TA, Olsson AH, Volkov P, Almgren P, Rönn T & Ling C 2013 Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets. Diabetologia 56 1036–1046. (doi:10.1007/s00125-012-2815-7)
23. Dayeh T, Volkov P, Salö S, Hall E, Nilsson E, Olsson AH, Kirkpatrick CL, Wollheim CB, Eliasson L, Rönn T et al. 2014 Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genetics 10 e1004160. (doi:10.1371/journal.pgen.1004160)
24. Dhawan S, Tschen S-I, Zeng C, Guo T, Hebrok M, Matveyenko A & Bhushan A 2015 DNA methylation directs functional maturation of pancreatic β cells. Journal of Clinical Invesigation 125 2851–2860. (doi:10.1172/JCI79956)
25. Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, Aïssi D, Wahl S, Meduri E, Morange P-E, Gagnon F, Grallert H et al. 2014 DNA methylation and body-mass index: a genome-wide analysis. Lancet 383 1990–1998. (doi:10.1016/S0140-6736(13)62674-4)
26. Dillon N 2006 Gene regulation and large-scale chromatin organization in the nucleus. Chromosome Research 14 117–126. (doi:10.1007/s10577-006-1027-8)
27. Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, Cesarkas K, Jacob-Hirsch J, Amariglio N, Kupiec M et al. 2012 Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485 201–206. (doi:10.1038/nature11112)
28. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL et al. 2010 New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nature Genetics 42 105–116. (doi:10.1038/ng.520)
29. Ellard S, Lango Allen H, De Franco E, Flanagan SE, Hysenaj G, Colclough K, Houghton JAL, Shepherd M, Hattersley AT, Weedon MN et al. 2013 Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia 56 1958–1963. (doi:10.1007/s00125-013-2962-5)
30. ENCODE Project Consortium, Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M et al. 2012 An integrated encyclopedia of DNA elements in the human genome. Nature 489 57–74. (doi:10.1038/nature11247)
31. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M et al. 2012 Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473 43–49. (doi:10.1038/nature09906)
32. Esteller M 2011 Non-coding RNAs in human disease. Nature Review Genetics 12 861–874. (doi:10.1038/nrg3074)
33. Fadista J, Vikman P, Laakso EO, Mollet IG, Esguerra JL, Taneera J, Storm P, Osmark P, Ladenvall C, Prasad RB et al. 2014 Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism. PNAS 111 13924–13929. (doi:10.1073/pnas.1402665111)
34. Farh KK-H, Marson A, Zhu J, Kleinewietfeld M, Housley WJ, Beik S, Shoresh N, Whitton H, Ryan RJH, Shishkin AA et al. 2015 Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518 337–343. (doi:10.1038/nature13835)
35. Flanagan SE, De Franco E, Lango Allen H, Zerah M, Abdul-Rasoul MM, Edge JA, Stewart H, Alamiri E, Hussain K, Wallis S et al. 2014 Analysis of transcription factors key for mouse pancreatic development establishes NKX2-2 and MNX1 mutations as causes of neonatal diabetes in man. Cell Metabolism 19 146–154. (doi:10.1016/j.cmet.2013.11.021)
36. Florez JC, Hirschhorn J & Altshuler D 2003 The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annual Review of Genomics and Human Genetics 4 257–291. (doi:10.1146/annurev.genom.4.070802.110436)
37. Fogarty MP, Panhuis TM, Vadlamudi S, Buchkovich ML & Mohlke KL 2013 Allele-specific transcriptional activity at type 2 diabetes-associated single nucleotide polymorphisms in regions of pancreatic islet open chromatin at the JAZF1 locus. Diabetes 62 1756–1762. (doi:10.2337/db12-0972)
38. Fogarty MP, Cannon ME, Vadlamudi S, Gaulton KJ & Mohlke KL 2014 Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/CAMK1D type 2 diabetes GWAS locus. PLoS Genetics 10 e1004633. (doi:10.1371/journal.pgen.1004633)
39. Fu Y, Dominissini D, Rechavi G & He C 2014 Gene expression regulation mediated through reversible m6A RNA methylation. Nature Review Genetics 15 293–306. (doi:10.1038/nrg3724)
40. Fustin J-M, Doi M, Yamaguchi Y, Hida H, Nishimura S, Yoshida M, Isagawa T, Morioka MS, Kakeya H, Manabe I et al. 2013 RNAmethylation-dependent RNA processing controls the speed of the circadian clock. Cell 155 793–806. (doi:10.1016/j.cell.2013.10.026)
41. Gao N, LeLay J, Vatamaniuk MZ, Rieck S, Friedman JR & Kaestner KH 2008 Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. Genes and Development 22 3435–3448. (doi:10.1101/gad.1752608)
42. Garin I, Edghill EL, Akerman I, Rubio-Cabezas O, Rica I, Locke JM, Maestro MA, Alshaikh A, Bundak R, del Castillo G et al. 2010 Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis. PNAS 107 3105–3110. (doi:10.1073/pnas.0910533107)
43. Gaulton KJ, Nammo T, Pasquali L, Simon JM, Giresi PG, Fogarty MP, Panhuis TM, Mieczkowski P, Secchi A, Bosco D et al. 2010 A map of open chromatin in human pancreatic islets. Nature Genetics 42 255–259. (doi:10.1038/ng.530)
44. Gilbert N, Boyle S, Fiegler H, Woodfine K, Carter NP & Bickmore WA 2004 Chromatin architecture of the human genome: gene-rich domains are enriched in open chromatin fibers. Cell 118 555–566. (doi:10.1016/j.cell.2004.08.011)
45. de Giorgio A, Krell J, Harding V, Stebbing J & Castellano L 2013 Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN. Molecular and Cell Biology 33 3976–3982. (doi:10.1128/MCB.00683-13)
46. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U & Shaw JE 2014 Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice 103 137–149. (doi:10.1016/j.diabres.2013.11.002)
47. Guelen L, Pagie L, Brasset E, Meuleman W, Faza MB, Talhout W, Eussen BH, deKlein A, Wessels L, de Laat W et al. 2008 Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 453 948–951. (doi:10.1038/nature06947)
48. Gulko B, Hubisz MJ, Gronau I & Siepel A 2015 A method for calculating probabilities of fitness consequences for point mutations across the human genome. Nature Genetics 47 276–283. (doi:10.1038/ng.3196)
49. Gusev A, Lee SH, Trynka G, Finucane H, Vilhjálmsson BJ, Xu H, Zang C, Ripke S, Bulik-Sullivan B, Stahl E et al. 2014 Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. American Journal of Human Genetics 95 535–552. (doi:10.1016/j.ajhg.2014.10.004)
50. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP et al. 2009 Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458 223–227. (doi:10.1038/nature07672)
51. Hansen TH, Vestergaard H, Jørgensen T, Jørgensen ME, Lauritzen T, Brandslund I, Christensen C, Pedersen O, Hansen T & Gjesing AP 2015 Impact of PTBP1 rs11085226 on glucose-stimulated insulin release in adult Danes. BMC Medical Genetics 16 4. (doi:10.1186/s12863-015-0162-7)
52. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM & Tilghman SM 2000 CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405 486–489. (doi:10.1038/35013106)
53. Haumaitre C, Barbacci E, Jenny M, Ott MO, Gradwohl G & Cereghini S 2005 Lack of TCF2/vHNF1 inmice leads to pancreas agenesis. PNAS 102 1490–1495. (doi:10.1073/pnas.0405776102)
54. Hidalgo B, Irvin MR, Sha J, Zhi D, Aslibekyan S, Absher D, Tiwari HK, Kabagambe EK, Ordovas JM & Arnett DK 2014 Epigenome-wide association study of fasting measures of glucose, insulin, and HOMA-IR in the Genetics of Lipid Lowering Drugs and Diet Network study. Diabetes 63 801–807. (doi:10.2337/db13-1100)
55. Hilton IB, D’Ippolito AM, Vockley CM, Thakore PI, Crawford GE, Reddy TE & Gersbach CA 2015 Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nature Biotechnology 33 510–517. (doi:10.1038/nbt.3199)
56. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-André V, Sigova AA, Hoke HA & Young RA 2013 Super-enhancers in the control of cell identity and disease. Cell 155 934–947. (doi:10.1016/j.cell.2013.09.053)
57. Hon GC, Song C-X, Du T, Jin F, Selvaraj S, Lee AY, Yen C-A, Ye Z, Mao S-Q, Wang B-A et al. 2014 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. Molecular Cell 56 286–297.(doi:10.1016/j.molcel.2014.08.026)
58. Hrvatin S, O’Donnell CW, Deng F, Millman JR, Pagliuca FW, DiIorio P, Rezania A, Gifford DK & Melton DA 2014 Differentiated human stem cells resemble fetal, not adult, β cells. PNAS 111 3038–3043. (doi:10.1073/pnas.1400709111)
59. Hua H, Hua H, Shang L, Shang L, Martinez H, Martinez H, Freeby M, Freeby M, Gallagher MP, Gallagher MP et al. 2013 iPSC-derived b cells model diabetes due to glucokinase deficiency. Journal of Clinical Invesigation 123 3146–3153. (doi:10.1172/JCI67638)
60. Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S et al. 2015 The landscape of long noncoding RNAs in the human transcriptome. Nature Genetics 47 199–208. (doi:10.1038/ng.3192)
61. Jacquemin P, Durviaux SM, Jensen J, Godfraind C, Gradwohl G, Guillemot F, Madsen OD, Carmeliet P, Dewerchin M, Collen D et al. 2000 Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine gene ngn3. Molecular and Cell Biology 20 4445–4454. (doi:10.1128/MCB.20.12.4445-4454.2000)
62. Jemal A, Ward E, Hao Y & Thun M 2005 Trends in the leading causes of death in the United States, 1970–2002. Journal of the American Medical Association 294 1255–1259. (doi:10.1001/jama.294.10.1255)
63. Jiang X, Ma H, Wang Y & Liu Y 2013 Early life factors and type 2 diabetes mellitus. Journal of Diabetes Research 2013 article 485082. (doi:10.1155/2013/485082)
64. Jones PA 2012 Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nature Review Genetics 13 484–492. (doi:10.1038/nrg3230)
65. Kameswaran V & Kaestner KH 2014 The missing lnc(RNA) between the pancreatic β-cell and diabetes. Frontiers in Genetics 5 200. (doi:10.3389/fgene.2014.00200)
66. Kameswaran V, Bramswig NC, McKenna LB, Penn M, Schug J, Hand NJ, Chen Y, Choi I, Vourekas A, Won K-J et al. 2014 Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell Metabolism 19 135–145. (doi:10.1016/j.cmet.2013.11.016)
67. Karambataki M, Malousi A & Kouidou S 2014 Risk-associated coding synonymous SNPs in type 2 diabetes and neurodegenerative diseases: genetic silence and the underrated association with splicing regulation and epigenetics. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 770 85–93. (doi:10.1016/j.mrfmmm.2014.09.005)
68. Kaspi H, Pasvolsky R & Hornstein E 2014 Could microRNAs contribute to the maintenance of β cell identity? Trends in Endocrinology and Metabolism 25 285–292. (doi:10.1016/j.tem.2014.01.003)
69. Keene JD 2007 RNA regulons: coordination of post-transcriptional events. Nature Review Genetics 8 533–543. (doi:10.1038/nrg2111)
70. Kellis M, Wold B, Snyder MP, Bernstein BE, Kundaje A, Marinov GK, Ward LD, Birney E, Crawford GE, Dekker J et al. 2014 Defining functional DNA elements in the human genome. PNAS 111 6131–6138. (doi:10.1073/pnas.1318948111)
71. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, iveaMorales D, Thomas K, Presser A, Bernstein BE, van Oudenaarden A et al. 2009 Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. PNAS 106 11667–11672. (doi:10.1073/pnas.0904715106)
72. Khoo C, Yang J, Weinrott SA, Kaestner KH, Naji A, Schug J & Stoffers DA 2012 Research resource: the pdx1 cistrome of pancreatic islets. Molecular Endocrinology 26 521–533. (doi:10.1210/me.2011-1231)
73. Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM & Shendure J 2014 A general framework for estimating the relative pathogenicity of human genetic variants. Nature Genetics 46 310–315. (doi:10.1038/ng.2892)
74. Köbberling J & Tillil H 1990 Genetic and nutritional factors in the etiology and pathogenesis of diabetes mellitus. World Review of Nutrition and Dietetics 63 102–115.
75. Kretz M, Siprashvili Z, Chu C, Webster DE, Zehnder A, Qu K, Lee CS, Flockhart RJ, Groff AF, Chow J et al. 2013 Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 493 231–235. (doi:10.1038/nature11661)
76. Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S & Sharpless NE 2006 p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443 453–457. (doi:10.1038/nature05092)
77. Kudva YC, Ohmine S, Greder LV, Dutton JR, Armstrong A, DeLamo JG, Khan YK, Thatava T, Hasegawa M, Fusaki N et al. 2012 Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes. Stem Cells Translational Medicine 1 451–461. (doi:10.5966/sctm.2011-0044)
78. Kulkarni H, Kos MZ, Neary J, Dyer TD, Göring HHH, Cole SA, Comuzzie AG, Almasy L, Mahaney MC, Curran JE et al. 2015 Novel epigenetic determinants of type 2 diabetes in mexican american families. Human Molecular Genetics 24 5330–5344. (doi:10.1093/hmg/ddv232)
79. Kulzer JR, Stitzel ML, Morken MA, Huyghe JR, Fuchsberger C, Kuusisto J, Laakso M, Boehnke M, Collins FS & Mohlke KL 2014 A common functional regulatory variant at a type 2 diabetes locus upregulates ARAP1 expression in the pancreatic β cell. American Journal of Human Genetics 94 186–197. (doi:10.1016/j.ajhg.2013.12.011)
80. Lai F, Orom UA, Cesaroni M, Beringer M, Taatjes DJ, Blobel GA & Shiekhattar R 2013 Activating RNAs associate with mediator to enhance chromatin architecture and transcription. Nature 494 497–501. (doi:10.1038/nature11884)
81. Lango Allen H, Flanagan SE, Shaw-Smith C, DeFranco E, Akerman I, Caswell R, International Pancreatic Agenesis Consortium, Ferrer J, Hattersley AT & Ellard S 2012 GATA6 haploinsufficiency causes pancreatic agenesis in humans. Nature Genetics 44 20–22. (doi:10.1038/ng.1035)
82. Latreille M, Hausser J, Stützer I, Zhang Q, Hastoy B, Gargani S, Kerr-Conte J, Pattou F, Zavolan M, Esguerra JLS et al. 2014 MicroRNA-7a regulates pancreatic b cell function. Journal of Clinical Invesigation 124 2722–2735. (doi:10.1172/JCI73066)
83. Lee D, Gorkin DU, Baker M, Strober BJ, Asoni AL, McCallion AS & Beer MA 2015 A method to predict the impact of regulatory variants from DNA sequence. Nature Genetics 47 955–961. (doi:10.1038/ng.3331)
84. Ling C, Del Guerra S, Lupi R, Rönn T, Granhall C, Luthman H, Masiello P, Marchetti P, Groop L & Del Prato S 2008 Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 51 615–622. (doi:10.1007/s00125-007-0916-5)
85. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo Q-M, Human DNA et al. 2009 methylomes at base resolution show widespread epigenomic differences. Nature 462 315–322. (doi:10.1038/nature08514)
86. Locke JM, da Silva Xavier G, Dawe HR, Rutter GA & Harries LW 2014 Increased expression of miR-187 in human islets from individuals with type 2 diabetes is associated with reduced glucose-stimulated insulin secretion. Diabetologia 57 122–128. (doi:10.1007/s00125-013-3089-4)
87. Locke JM, Hysenaj G, Wood AR, Weedon MN & Harries LW 2015 Targeted allelic expression profiling in human islets identifies cis-regulatory effects for multiple variants identified by type 2 diabetes genome-wide association studies. Diabetes 64 1484–1491. (doi:10.2337/db14-0957)
88. Lu F, Liu Y, Jiang L, Yamaguchi S & Zhang Y 2014 Role of Tet proteins in enhancer activity and telomere elongation. Genes and Development 28 2103–2119. (doi:10.1101/gad.248005.114)
89. Lupiáñez DG, Kraft K, Heinrich V, Krawitz P, Brancati F, Klopocki E, Horn D, Kayserili H, Opitz JM, Laxova R et al. 2015 Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions. Cell 161 1012–1025. (doi:10.1016/j.cell.2015.04.004)
90. Lynn FC, Skewes-Cox P, Kosaka Y, McManus MT, Harfe BD & German MS 2007 MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes 56 2938–2945. (doi:10.2337/db07-0175)
91. Maas S, Kawahara Y, Tamburro KM & Nishikura K 2006 A-to-I RNA editing and human disease. RNA Biology 3 1–9. (doi:10.4161/rna.3.1.2495)
92. Maehr R, Chen S, Snitow M, Snitow M, Ludwig T, Ludwig T, Yagasaki L, Yagasaki L, Goland R, Goland R et al. 2009 Generation of pluripotent stem cells from patients with type 1 diabetes. PNAS 106 15768–15773. (doi:10.1073/pnas.0906894106)
93. Magro MG & Solimena M 2013 Regulation of β-cell function by RNA-binding proteins. Molecular Metabolism 2 348–355. (doi:10.1016/j.molmet.2013.09.003)
94. Manning AK, Hivert M-F, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H, Rybin D, Liu C-T, Bielak LF, Prokopenko I et al. 2012 A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nature Genetics 44 659–669. (doi:10.1038/ng.2274)
95. Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, Reynolds AP, Sandstrom R, Qu H, Brody J et al. 2012 Systematic localization of common disease-associated variation in regulatory DNA. Science 337 1190–1195. (doi:10.1126/science.1222794)
96. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JPA & Hirschhorn JN 2008 Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Review Genetics 9 356–369. (doi:10.1038/nrg2344)
97. Melé M, Ferreira PG, Reverter F, DeLuca DS, Monlong J, Sammeth M, Young TR, Goldmann JM, Pervouchine DD, Sullivan TJ et al. 2015 Human genomics. The human transcriptome across tissues and individuals. Science 348 660–665. (doi:10.1126/science.aaa0355)
98. Melkman-Zehavi T, Oren R, Kredo-Russo S, Shapira T, Mandelbaum AD, Rivkin N, Nir T, Lennox KA, Behlke MA, Dor Y et al. 2011 miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors. EMBO Journal 30 835–845. (doi:10.1038/emboj.2010.361)
99. Morán I, Akerman I, van de Bunt M, Xie R, Benazra M, Nammo T, Arnes L, Nakić N, García-Hurtado J, Ríodrguez-Seguí S et al. 2012 Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metabolism 16 435–448. (doi:10.1016/j.cmet.2012.08.010)
100. Nair G & Hebrok M 2015 Islet formation in mice and men: lessons for the generation of functional insulin-producing β-cells from human pluripotent stem cells. Current Opinion in Genetics & Development 32 171–180. (doi:10.1016/j.gde.2015.03.004)
101. Nica AC, Ongen H, Irminger J-C, Bosco D, Berney T, Antonarakis SE, Halban PA & Dermitzakis ET 2013 Cell-type, allelic, and genetic signatures in the human pancreatic β cell transcriptome. Genome Research 23 1554–1562. (doi:10.1101/gr.150706.112)
102. Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, Hogan BL & Wright CV 1996 PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122 983–995.
103. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C & Huang Q 2010 Long noncoding RNAs with enhancer-like function in human cells. Cell 143 46–58. (doi:10.1016/j.cell.2010.09.001)
104. Orozco LD, Morselli M, Rubbi L, Guo W, Go J, Shi H, Lopez D, Furlotte NA, Bennett BJ, Farber CR et al. 2015 Epigenome-wide association of liver methylation patterns and complex metabolic traits in mice. Cell Metabolism 21 905–917. (doi:10.1016/j.cmet.2015.04.025)
105. Ouaamari EA, Baroukh N, Martens GA, Lebrun P, Pipeleers D & vanObberghen E 2008 miR-375 targets 3’-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic β-cells. Diabetes 57 2708–2717. (doi:10.2337/db07-1614)
106. Pagliuca FW, Millman JR, Gürtler M, Segel M, Van Dervort A, Ryu JH, Peterson QP, Greiner D & Melton DA 2014 Generation of functional human pancreatic b cells in vitro. Cell 159 428–439. (doi:10.1016/j.cell. 2014.09.040)
107. Parker SCJ, Stitzel ML, Taylor DL, Orozco JM, Erdos MR, Akiyama JA, vanBueren KL, Chines PS, Narisu N, NISC Comparative Sequencing Program et al. 2013 Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. PNAS 110 17921–17926. (doi:10.1073/pnas.1317023110)
108. Pasmant E, Sabbagh A, Vidaud M & Bièche I 2011 ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB Journal 25 444–448. (doi:10.1096/fj.10-172452)
109. Pasquali L, Gaulton KJ, Roídrguez-Seguí SA, Mularoni L, Miguel-Escalada I, Akerman I, Tena JJ, Morán I, Gómez-Marín C, van deunt M et al. 2014 Pancreatic islet enhancer clusters enriched in type 2 diabetes riskassociated variants. Nature Genetics 46 136–143. (doi:10.1038/ng.2870)
110. Pennacchio LA & Visel A 2010 Limits of sequence and functional conservation. Nature Genetics 42 557–558. (doi:10.1038/ng0710-557)
111. Perry JRB & Frayling TM 2008 New gene variants alter type 2 diabetes risk predominantly through reduced β-cell function. Current Opinion in Clinical Nutrition and Metabolic Care 11 371–377. (doi:10.1097/MCO.0b013e32830349a1)
112. Petersen A-K, Zeilinger S, Kastenmüller G, Römisch-Margl W, Brugger M, Peters A, Meisinger C, Strauch K, Hengstenberg C, Pagel P et al. 2014 Epigenetics meets metabolomics: an epigenome-wide association study with blood serum metabolic traits. Human Molecular Genetics 23 534–545. (doi:10.1093/hmg/ddt430)
113. Poulsen P, Kyvik KO, Vaag A & Beck-Nielsen H 1999 Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance – a population-based twin study. Diabetologia 42 139–145. (doi:10.1007/s001250051131)
114. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, MacDonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P et al. 2004 A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432 226–230. (doi:10.1038/nature03076)
115. Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, Vergara IA, Davicioni E, Erho N, Ghadessi M et al. 2013 The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nature Genetics 45 1392–1398. (doi:10.1038/ng.2771)
116. Pullen TJ & Rutter GA 2014 Roles of lncRNAs in pancreatic β cell identity and diabetes susceptibility. Frontiers in Genetics 5 193. (doi:10.3389/fgene.2014.00193)
117. Ravassard P, Hazhouz Y, Pechberty S, Bricout-Neveu E, Armanet M, Czernichow P & Scharfmann R 2011 A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion. Journal of Clinical Invesigation 121 3589–3597. (doi:10.1172/JCI58447)
118. Rezania A, Bruin JE, Arora P, Rubin A, Batushansky I, Asadi A, O’Dwyer S, Quiskamp N, Mojibian M, Albrecht T et al. 2014 Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nature Biotechnology 32 1121–1133. (doi:10.1038/nbt.3033)
119. Rinn JL & Chang HY 2012 Genome regulation by long noncoding RNAs. Annual Review of Biochemistry 81 145–166. (doi:10.1146/annurevbiochem-051410-092902)
120. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E et al. 2007 Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129 1311–1323. (doi:10.1016/j.cell.2007.05.022)
121. Ritchie GRS, Dunham I, Zeggini E & Flicek P 2014 Functional annotation of noncoding sequence variants. Nature Methods 11 294–296. (doi:10.1038/nmeth.2832)
122. Roadmap Epigenomics Consortium, Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, Heravi-Moussavi A, Kheradpour P, Zhang Z & Wang J 2015 Integrative analysis of 111 reference human epigenomes. Nature 518 317–330. (doi:10.1038/nature14248)
123. Robertson KD 2005 DNA methylation and human disease. Nature Review Genetics 6 597–610. (doi:10.1038/nrg1655)
124. Russ HA, Russ HA, Parent AV, Parent AV, Ringler JJ, Ringler JJ, Hennings TG, Hennings TG, Nair GG, Nair GG et al. 2015 Controlled induction of human pancreatic progenitors produces functional β-like cells in vitro. EMBO Journal 34 1759–1772. (doi:10.15252/embj.201591058)
125. Salmena L, Poliseno L, Tay Y, Kats L & Pandolfi PP 2011 A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell 146 353–358. (doi:10.1016/j.cell.2011.07.014)
126. Scharfmann R, Pechberty S, Hazhouz Y, Bülow von M, Bricout-Neveu E, Grenier-Godard M, Guez F, Rachdi L, Lohmann M, Czernichow P et al. 2014 Development of a conditionally immortalized human pancreatic β cell line. Journal of Clinical Invesigation 124 2087–2098. (doi:10.1172/JCI72674)
127. Schork NJ, Murray SS, Frazer KA & Topol EJ 2009 Common vs. rare allele hypotheses for complex diseases. Current Opinion in Genetics & Development 19 212–219. (doi:10.1016/j.gde.2009.04.010)
128. Schübeler D 2015 Function and information content of DNA methylation. Nature 517 321–326. (doi:10.1038/nature14192)
129. Schultz MD, He Y, Whitaker JW, Hariharan M, Mukamel EA, Leung D, Rajagopal N, Nery JR, Urich MA, Chen H et al. 2015 Human body epigenome maps reveal noncanonical DNA methylation variation. Nature 523 212–216. (doi:10.1038/nature14465)
130. Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J, Mägi R, Strawbridge RJ, Rehnberg E, Gustafsson S et al. 2012 Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nature Genetics 44 991–1005. (doi:10.1038/ng.2385)
131. Sellick GS, Barker KT, Stolte-Dijkstra I, Fleischmann C, Coleman RJ, Garrett C, Gloyn AL, Edghill EL, Hattersley AT, Wellauer PK et al. 2004 Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nature Genetics 36 1301–1305. (doi:10.1038/ng1475)
132. Seymour PA, Freude KK, Tran MN, Mayes EE, Jensen J, Kist R, Scherer G & Sander M 2007 SOX9 is required for maintenance of the pancreatic progenitor cell pool. PNAS 104 1865–1870. (doi:10.1073/pnas.0609217104)
133. Shaw-Smith C, De Franco E, Allen HL, Batlle M, Flanagan SE, Borowiec M, Taplin CE, van Alfen-van der Velden J, Cruz-Rojo J, de Nanclares GP et al. 2014 GATA4 mutations are a cause of neonatal and childhoodonset diabetes. Diabetes 63 DB_140061–DB_142894. (doi:10.2337/db14-0061)
134. Shen F, Huang W, Huang J-T, Xiong J, Yang Y, Wu K, Jia G-F, Chen J, Feng Y-Q, Yuan B-F et al. 2014 Decreased N6-methyladenosine in peripheral blood RNA from diabetic patients Is associated with FTO expression rather than ALKBH5. Journal of Clinical Endocrinology and Metabolism 100 E148–E154. (doi:10.1210/jc.2014-1893)
135. Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT & Ellard S 2010 Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53 2504–2508. (doi:10.1007/s00125-010-1799-4)
136. Shlyueva D, Stampfel G & Stark A 2014 Transcriptional enhancers: from properties to genome-wide predictions. Nature Review Genetics 15 272–286. (doi:10.1038/nrg3682)
137. Siddiqui K, Musambil M & Nazir N 2015 Maturity onset diabetes of the young (MODY)–history, first case reports and recent advances. Gene 555 66–71. (doi:10.1016/j.gene.2014.09.062)
138. Smemo S, Tena JJ, Kim K-H, Gamazon ER, Sakabe NJ, Gómez-Marín C, Aneas I, Credidio FL, Sobreira DR, Wasserman NF et al. 2014 Obesityassociated variants within FTO form long-range functional connections with IRX3. Nature 507 371–375. (doi:10.1038/nature13138)
139. Song L, Zhang Z, Grasfeder LL, Boyle AP, Giresi PG, Lee B-K, Sheffield NC, Gräf S, Huss M, Keefe D et al. 2011 Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Research 21 1757–1767. (doi:10.1101/gr.121541.111)
140. Stitzel ML, Sethupathy P, Pearson DS, Chines PS, Song L, Erdos MR, Welch R, Parker SCJ, Boyle AP, Scott LJ et al. 2010 Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. Cell Metabolism 12 443–455. (doi:10.1016/j.cmet.2010.09.012)
141. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL & Habener JF 1997 Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nature Genetics 15 106–110. (doi:10.1038/ng0197-106)
142. Taylor BL, Liu F-F & Sander M 2013 Nkx6.1 is essential for maintaining the functional state of pancreatic β cells. Cell Reports 4 1262–1275. (doi:10.1016/j.celrep.2013.08.010)
143. Teo AKK, Teo AKK, Windmueller R, Windmueller R, Johansson BB, Johansson BB, Dirice E, Njolstad PR, Njolstad PR, Tjora E et al. 2013 Derivation of human induced pluripotent stem cells from patients with maturity onset diabetes of the young. Journal of Biological Chemistry 288 5353–5356. (doi:10.1074/jbc.C112.428979)
144. Thatava T, Kudva YC, Edukulla R, Edukulla R, Squillace K, Squillace K, DeLamo JG, Khan YK, Sakuma T, Sakuma T et al. 2013 Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Molecular Therapy 21 228–239. (doi:10.1038/mt.2012.245)
145. The FANTOM Consortium 2005 The transcriptional landscape of the mammalian genome. Science 309 1559–1563. (doi:10.1126/science.1112014)
146. Tillmar L, Carlsson C & Welsh N 2002 Control of insulin mRNA stability in rat pancreatic islets. Regulatory role of a 3’-untranslated region pyrimidine-rich sequence. Journal of Biological Chemistry 277 1099–1106. (doi:10.1074/jbc.M108340200)
147. Vaxillaire M, Bonnefond A & Froguel P 2012 The lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis. Best Practice & Research. Clinical Endocrinology & Metabolism 26 171–187. (doi:10.1016/j.beem.2011.12.001)
148. Volkmar M, Dedeurwaerder S, Cunha DA, Ndlovu MN, Defrance M, Deplus R, Calonne E, Volkmar U, Igoillo-Esteve M, Naamane N et al. 2012 DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO Journal 31 1405–1426. (doi:10.1038/emboj.2011.503)
149. Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta RA et al. 2011 A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472 120–124. (doi:10.1038/nature09819)
150. Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L, Wu M, Xiong J, Guo X & Liu H 2013 Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog and Sox2 in human embryonic stem cell self-renewal. Developmental Cell 25 69–80. (doi:10.1016/j.devcel.2013.03.002)
151. Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, Fu Y, Parisien M, Dai Q, Jia G et al. 2014 N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505 117–120. (doi:10.1038/nature12730)
152. Wang A, Yue F, Li Y, Xie R, Harper T, Patel NA, Muth K, Palmer J, Qiu Y, Wang J et al. 2015a Epigenetic priming of enhancers predicts developmental competence of hESC-derived endodermal lineage intermediates. Cell Stem Cell 16 386–399. (doi:10.1016/j.stem.2015. 02.013)
153. Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, Weng X, Chen K, Shi H & He C 2015b N6-methyladenosine modulates messenger RNA translation efficiency. Cell 161 1388–1399. (doi:10.1016/j.cell.2015. 05.014)
154. Weedon MN, Cebola I, Flanagan SE, DeFranco E, Caswell R, Roídrguez-Seguí SA, Shaw-Smith C, Lango Allen H, Vallier L, International Pancreatic Agenesis Consortium et al. 2014 Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis. Nature Genetics 46 61–64. (doi:10.1038/ng.2826)
155. Wicksteed B, Uchizono Y, Alarcon C, McCuaig JF, Shalev A & Rhodes CJ 2007 A cis-element in the 5’ untranslated region of the preproinsulin mRNA (ppIGE) is required for glucose regulation of proinsulin translation. Cell Metabolism 5 221–227. (doi:10.1016/j.cmet.2007.02. 007)
156. Wiench M, John S, Baek S, Johnson TA, Sung M-H, Escobar T, Simmons CA, Pearce KH, Biddie SC, Sabo PJ et al. 2011 DNA methylation status predicts cell type-specific enhancer activity. EMBO Journal 30 3028–3039. (doi:10.1038/emboj.2011.210)
157. Willems SM, Mihaescu R, Sijbrands EJG, van Duijn CM & Janssens ACJW 2011 Amethodological perspective on genetic risk prediction studies in type 2 diabetes: recommendations for future research. Current Diabetes Reports 11 511–518. (doi:10.1007/s11892-011-0235-6)
158. Wirsing A, Senkel S, Klein-Hitpass L & Ryffel GU 2011 A systematic analysis of the 3'UTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites. PLoS ONE 6 e27438. (doi:10.1371/journal.pone.0027438)
159. Wu D, Yang G, Zhang L, Xue J, Wen Z & Li M 2014 Genome-wide association study combined with biological context can reveal more disease-related SNPs altering microRNA target seed sites. BMC Genomics 15 669. (doi:10.1186/1471-2164-15-669)
160. Xing Z, Lin A, Li C, Liang K, Wang S, Liu Y, Park PK, Qin L, Wei Y, Hawke DH et al. 2014 lncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell 159 1110–1125. (doi:10.1016/j.cell.2014.10.013)
161. Xuan S, Borok MJ, Decker KJ, Battle MA, Duncan SA, Hale MA, Macdonald RJ & Sussel L 2012 Pancreas-specific deletion of mouse Gata4 and Gata6 causes pancreatic agenesis. Journal of Clinical Invesigation 122 3516–3528. (doi:10.1172/JCI63352)
162. Yamanaka S 2007 Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1 39–49. (doi:10.1016/j.stem.2007.05.012)
163. Yang BT, Dayeh TA, Volkov PA, Kirkpatrick CL, Malmgren S, Jing X, Renström E, Wollheim CB, Nitert MD & Ling C 2012 Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Molecular Endocinology 26 1203–1212. (doi:10.1210/me.2012-1004)
164. Yap KL, Li S, Muñoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ & Zhou M-M 2010 Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Molecular Cell 38 662–674. (doi:10.1016/j.molcel.2010.03.021)
165. Yuan W, Xia Y, Bell CG, Yet I, Ferreira T, Ward KJ, Gao F, Loomis AK, Hyde CL, Wu H et al. 2014 An integrated epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic twins. Nature Communications 5 5719. (doi:10.1038/ncomms6719)